Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides. 2017

Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University , Cardiff, CF10 3NB, U.K.

Following our findings on the anti-human immunodeficiency virus (HIV) activity of acyclovir (ACV) phosphate prodrugs, we herein report the ProTide approach applied to a series of acyclic nucleosides aimed at the identification of novel and selective antiviral, in particular anti-HIV agents. Acyclic nucleoside analogues used in this study were identified through a virtual screening using HIV-reverse transcriptase (RT), adenylate/guanylate kinase, and human DNA polymerase γ. A total of 39 new phosphate prodrugs were synthesized and evaluated against HIV-1 (in vitro and ex vivo human tonsillar tissue system) and human herpes viruses. Several ProTide compounds showed substantial potency against HIV-1 at low micromolar range while the parent nucleosides were not effective. Also, pronounced inhibition of herpesvirus replication was observed. A carboxypeptidase-mediated hydrolysis study was performed for a selection of compounds to assess the formation of putative metabolites and support the biological activity observed.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
January 2024, Molecular diversity,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
May 2020, Bioorganic & medicinal chemistry,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
September 1994, Journal of medicinal chemistry,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
September 2019, European journal of medicinal chemistry,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
June 2000, Bioorganic & medicinal chemistry,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
December 2010, Journal of agricultural and food chemistry,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
April 2017, European journal of medicinal chemistry,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
January 2018, Antiviral research,
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
January 2015, Medicinal chemistry (Shariqah (United Arab Emirates)),
Marco Derudas, and Christophe Vanpouille, and Davide Carta, and Sonia Zicari, and Graciela Andrei, and Robert Snoeck, and Andrea Brancale, and Leonid Margolis, and Jan Balzarini, and Christopher McGuigan
January 2013, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!